Drug Safety Solutions and pharmacovigilance consultancy and support services offered by market players in order to ensure pharmaceutical developers meet industry regulatory standards. The companies engaged in this business consistently updates its regulatory knowledge to keep up with industry trends. Various government regulatory bodies (such as the U.S. FDA and EMEA) have intensified safety regulations for prior and post commercialization of drugs, which has increased pressure on the pharmaceutical and biotechnology companies to manufacture safe drugs and evaluate their results post sales. Thus, growing complexity related to drug safety regulations is expected to drive the growth of the market during the forecast period.
MARKET DYNAMICS
Drug safety solutions and pharmacovigilance market is driving due to factors such as increase in R & D expenditure by pharmaceutical and biopharmaceutical companies and increase in the number of adverse drug reactions (ADRS). However, factors such as, high cost of drug safety solutions & pharmacovigilance services is expected to hamper the market growth.
MARKET SCOPE
The Drug safety solutions and pharmacovigilance market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Drug safety solutions and pharmacovigilance market with detailed market segmentation by model type, service, therapeutic area, technology and end user. The Drug safety solutions and pharmacovigilance market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Drug safety solutions and pharmacovigilance market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Drug safety solutions and pharmacovigilance market is segmented on the basis of type and end user. Based on type, the market is segmented as Softwares, Services. Based on end users, market is segmented as Pharma and Biotech Companies, Contract Research Organizations (CROs), Business Process Outsourcing (BPO) Firms, Other Pharmacovigilance Service Providers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Drug safety solutions and pharmacovigilance market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Drug safety solutions and pharmacovigilance market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Drug safety solutions and pharmacovigilance market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Drug safety solutions and pharmacovigilance market in these regions.
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Drug safety solutions and pharmacovigilance market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Drug safety solutions and pharmacovigilance market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Drug safety solutions and pharmacovigilance market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Drug safety solutions and pharmacovigilance market in these regions.
MARKET PLAYERS
The report covers key developments in the Drug safety solutions and pharmacovigilance market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Drug safety solutions and pharmacovigilance market are anticipated to have lucrative growth opportunities in the future with the rising demand for Drug safety solutions and pharmacovigilance in the global market. Below mentioned is the list of few companies engaged in the Drug safety solutions and pharmacovigilance market.
The report also includes the profiles of key players in Drug safety solutions and Pharmacovigilance market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Pharmaceutical Product Development, LLC.
- Drug Safety Solutions Limited
- Syneos Health
- Worldwide Clinical Trials
- Bioclinica
- United Biosource LLC.
- Ennov
- IQVIA
- Covance Inc.
- Parexel International Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Drug Safety Solutions And Pharmacovigilance Market - By Type
1.3.2 Drug Safety Solutions And Pharmacovigilance Market - By End Users
1.3.3 Drug Safety Solutions And Pharmacovigilance Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET - GLOBAL MARKET ANALYSIS
6.1. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE - GLOBAL MARKET OVERVIEW
6.2. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SOFTWARES
7.3.1. Overview
7.3.2. Softwares Market Forecast and Analysis
7.4. SERVICES
7.4.1. Overview
7.4.2. Services Market Forecast and Analysis
8. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET - REVENUE AND FORECASTS TO 2028 - END USERS
8.1. OVERVIEW
8.2. END USERS MARKET FORECASTS AND ANALYSIS
8.3. PHARMA AND BIOTECH COMPANIES
8.3.1. Overview
8.3.2. Pharma and Biotech Companies Market Forecast and Analysis
8.4. CONTRACT RESEARCH ORGANIZATIONS (CROS)
8.4.1. Overview
8.4.2. Contract Research Organizations (CROs) Market Forecast and Analysis
8.5. BUSINESS PROCESS OUTSOURCING (BPO) FIRMS
8.5.1. Overview
8.5.2. Business Process Outsourcing (BPO) Firms Market Forecast and Analysis
8.6. OTHER PHARMACOVIGILANCE SERVICE PROVIDERS
8.6.1. Overview
8.6.2. Other Pharmacovigilance Service Providers Market Forecast and Analysis
9. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Drug Safety Solutions And Pharmacovigilance Market Overview
9.1.2 North America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis
9.1.3 North America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Type
9.1.4 North America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By End Users
9.1.5 North America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Countries
9.1.5.1 United States Drug Safety Solutions And Pharmacovigilance Market
9.1.5.1.1 United States Drug Safety Solutions And Pharmacovigilance Market by Type
9.1.5.1.2 United States Drug Safety Solutions And Pharmacovigilance Market by End Users
9.1.5.2 Canada Drug Safety Solutions And Pharmacovigilance Market
9.1.5.2.1 Canada Drug Safety Solutions And Pharmacovigilance Market by Type
9.1.5.2.2 Canada Drug Safety Solutions And Pharmacovigilance Market by End Users
9.1.5.3 Mexico Drug Safety Solutions And Pharmacovigilance Market
9.1.5.3.1 Mexico Drug Safety Solutions And Pharmacovigilance Market by Type
9.1.5.3.2 Mexico Drug Safety Solutions And Pharmacovigilance Market by End Users
9.2. EUROPE
9.2.1 Europe Drug Safety Solutions And Pharmacovigilance Market Overview
9.2.2 Europe Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis
9.2.3 Europe Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Type
9.2.4 Europe Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By End Users
9.2.5 Europe Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Drug Safety Solutions And Pharmacovigilance Market
9.2.5.1.1 Germany Drug Safety Solutions And Pharmacovigilance Market by Type
9.2.5.1.2 Germany Drug Safety Solutions And Pharmacovigilance Market by End Users
9.2.5.2 France Drug Safety Solutions And Pharmacovigilance Market
9.2.5.2.1 France Drug Safety Solutions And Pharmacovigilance Market by Type
9.2.5.2.2 France Drug Safety Solutions And Pharmacovigilance Market by End Users
9.2.5.3 Italy Drug Safety Solutions And Pharmacovigilance Market
9.2.5.3.1 Italy Drug Safety Solutions And Pharmacovigilance Market by Type
9.2.5.3.2 Italy Drug Safety Solutions And Pharmacovigilance Market by End Users
9.2.5.4 Spain Drug Safety Solutions And Pharmacovigilance Market
9.2.5.4.1 Spain Drug Safety Solutions And Pharmacovigilance Market by Type
9.2.5.4.2 Spain Drug Safety Solutions And Pharmacovigilance Market by End Users
9.2.5.5 United Kingdom Drug Safety Solutions And Pharmacovigilance Market
9.2.5.5.1 United Kingdom Drug Safety Solutions And Pharmacovigilance Market by Type
9.2.5.5.2 United Kingdom Drug Safety Solutions And Pharmacovigilance Market by End Users
9.2.5.6 Rest of Europe Drug Safety Solutions And Pharmacovigilance Market
9.2.5.6.1 Rest of Europe Drug Safety Solutions And Pharmacovigilance Market by Type
9.2.5.6.2 Rest of Europe Drug Safety Solutions And Pharmacovigilance Market by End Users
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Drug Safety Solutions And Pharmacovigilance Market Overview
9.3.2 Asia-Pacific Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis
9.3.3 Asia-Pacific Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By End Users
9.3.5 Asia-Pacific Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Drug Safety Solutions And Pharmacovigilance Market
9.3.5.1.1 Australia Drug Safety Solutions And Pharmacovigilance Market by Type
9.3.5.1.2 Australia Drug Safety Solutions And Pharmacovigilance Market by End Users
9.3.5.2 China Drug Safety Solutions And Pharmacovigilance Market
9.3.5.2.1 China Drug Safety Solutions And Pharmacovigilance Market by Type
9.3.5.2.2 China Drug Safety Solutions And Pharmacovigilance Market by End Users
9.3.5.3 India Drug Safety Solutions And Pharmacovigilance Market
9.3.5.3.1 India Drug Safety Solutions And Pharmacovigilance Market by Type
9.3.5.3.2 India Drug Safety Solutions And Pharmacovigilance Market by End Users
9.3.5.4 Japan Drug Safety Solutions And Pharmacovigilance Market
9.3.5.4.1 Japan Drug Safety Solutions And Pharmacovigilance Market by Type
9.3.5.4.2 Japan Drug Safety Solutions And Pharmacovigilance Market by End Users
9.3.5.5 South Korea Drug Safety Solutions And Pharmacovigilance Market
9.3.5.5.1 South Korea Drug Safety Solutions And Pharmacovigilance Market by Type
9.3.5.5.2 South Korea Drug Safety Solutions And Pharmacovigilance Market by End Users
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market Overview
9.4.2 Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis
9.4.3 Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By End Users
9.4.5 Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Drug Safety Solutions And Pharmacovigilance Market
9.4.5.1.1 South Africa Drug Safety Solutions And Pharmacovigilance Market by Type
9.4.5.1.2 South Africa Drug Safety Solutions And Pharmacovigilance Market by End Users
9.4.5.2 Saudi Arabia Drug Safety Solutions And Pharmacovigilance Market
9.4.5.2.1 Saudi Arabia Drug Safety Solutions And Pharmacovigilance Market by Type
9.4.5.2.2 Saudi Arabia Drug Safety Solutions And Pharmacovigilance Market by End Users
9.4.5.3 U.A.E Drug Safety Solutions And Pharmacovigilance Market
9.4.5.3.1 U.A.E Drug Safety Solutions And Pharmacovigilance Market by Type
9.4.5.3.2 U.A.E Drug Safety Solutions And Pharmacovigilance Market by End Users
9.4.5.4 Rest of Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market
9.4.5.4.1 Rest of Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market by Type
9.4.5.4.2 Rest of Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market by End Users
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Drug Safety Solutions And Pharmacovigilance Market Overview
9.5.2 South and Central America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis
9.5.3 South and Central America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Type
9.5.4 South and Central America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By End Users
9.5.5 South and Central America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Drug Safety Solutions And Pharmacovigilance Market
9.5.5.1.1 Brazil Drug Safety Solutions And Pharmacovigilance Market by Type
9.5.5.1.2 Brazil Drug Safety Solutions And Pharmacovigilance Market by End Users
9.5.5.2 Argentina Drug Safety Solutions And Pharmacovigilance Market
9.5.5.2.1 Argentina Drug Safety Solutions And Pharmacovigilance Market by Type
9.5.5.2.2 Argentina Drug Safety Solutions And Pharmacovigilance Market by End Users
9.5.5.3 Rest of South and Central America Drug Safety Solutions And Pharmacovigilance Market
9.5.5.3.1 Rest of South and Central America Drug Safety Solutions And Pharmacovigilance Market by Type
9.5.5.3.2 Rest of South and Central America Drug Safety Solutions And Pharmacovigilance Market by End Users
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET, KEY COMPANY PROFILES
12.1. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. DRUG SAFETY SOLUTIONS LIMITED
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SYNEOS HEALTH
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. WORLDWIDE CLINICAL TRIALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BIOCLINICA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. UNITED BIOSOURCE LLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ENNOV
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. IQVIA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. COVANCE INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PAREXEL INTERNATIONAL CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Pharmaceutical Product Development, LLC.
2. Drug Safety Solutions Limited
3. Syneos Health
4. Worldwide Clinical Trials
5. Bioclinica
6. United Biosource LLC.
7. Ennov
8. IQVIA
9. Covance Inc.
10. Parexel International Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Drug Safety Solutions And Pharmacovigilance Market
Apr 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2024
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)